A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2)Ralph V. Boccia, James R. Berenson, Wael A. Harb et al.|Clinical Lymphoma Myeloma & Leukemia|2017Cited by 19
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2)Ralph V. Boccia, James R. Berenson, Alberto Bessudo et al.|Blood|2016Cited by 4